T1	Participants 0 41	Veterans Affairs congestive heart failure
T2	Participants 222 287	patients with congestive heart failure and ventricular arrhythmia
T3	Participants 289 354	Patients will be assigned to receive either amiodarone or placebo
T4	Participants 504 752	patients must have shortness of breath with minimal exertion or paroxysmal nocturnal dyspnea, a left ventricular internal dimension (LVIDd) by echocardiogram of > or = 55 mm or a cardiothoracic ratio of > 0.5 and an ejection fraction of < or = 40%.
T5	Participants 356 499	Eligible patients include those with ischemic and nonischemic congestive heart failure and with > or = 10 ventricular premature beats per hour.
T6	Participants 1101 1174	674 patients will be entered into the study from 25 participating centers
